InspireMD (NASDAQ: NSPR) reported Q1 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.51 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.